Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967511 · ClinicalTrials.gov registry record
Defining the Basis of Fibromuscular Dysplasia (FMD)
A clinical trial of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT01967511: Recruiting study of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01967511 is a study of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 600 participants, below the 768-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01967511, a study of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects. While this remains among the objectives, the study has been expanded to undertake a fully powered cross-tissue systems genetics analysis of FMD, and now also the related arteriopathies spontaneous coronary artery dissection (SCAD) and cervical artery dissection (CvAD). The overall objective is to disclose the core biologic mechanisms of these disorders.
Primary Outcome
The identification of regulatory gene networks, and their key drivers, underlying FMD, SCAD and CvAD
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-10 |
| Est. Completion | 2030-12 |
What NCT01967511 shows while recruiting
NCT01967511 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 768-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (22% lower).
The record links to 3 conditions, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.
NCT01967511 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01967511 about?
NCT01967511 is a clinical study titled "Defining the Basis of Fibromuscular Dysplasia (FMD)". The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects. While this remains among the obje...
What is the current status of trial NCT01967511?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2013-10. Estimated completion is 2030-12.
What conditions does trial NCT01967511 study?
This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, Fibromuscular Dysplasia.
Who is sponsoring clinical trial NCT01967511?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01967511 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spontaneous Coronary Artery Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry
RECRUITING
-
A Study of SCAD Using Stress Contrast Echocardiography
RECRUITING
-
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
RECRUITING · NA
-
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
RECRUITING
-
Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia